Statin Therapy Dose and Risk of New-Onset Diabetes Reply

被引：1
|
作者：
Preiss, David [1 ]
Seshasai, Sreenivasa Rao Kondapally [2 ]
Ray, Kausik K. [3 ]
机构：
[1] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[2] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England
[3] St Georges Univ London, Div Cardiac & Vasc Sci, London, England
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2011年 / 306卷 / 12期
关键词：
RANDOMIZED-TRIALS; METAANALYSIS; EFFICACY; SAFETY;
D O I：
10.1001/jama.2011.1355
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1326 / 1326
页数：1
相关论文
共 50 条
  • [1] Statin Therapy Dose and Risk of New-Onset Diabetes
    McEvoy, John W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (12): : 1325 - 1326
  • [2] Statin therapy and new-onset diabetes: an attempt at recommendations
    Banach, Maciej
    Mikhailidis, Dimitri P.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (03) : 213 - 216
  • [3] Statin therapy and new-onset diabetes: A cause for concern?
    Preiss, David
    MATURITAS, 2012, 72 (02) : 95 - 96
  • [4] Risk of new-onset diabetes associated with statin use
    Beckett, Robert D.
    Schepers, Sarah M.
    Gordon, Sarah K.
    SAGE OPEN MEDICINE, 2015, 3
  • [5] Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy?
    Navarese, Eliano Pio
    Szczesniak, Anna
    Kolodziejczak, Michalina
    Gorny, Bartosz
    Kubica, Jacek
    Suryapranata, Harry
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2014, 14 (02) : 79 - 87
  • [6] Statin therapy and related risk of new-onset type 2 diabetes mellitus
    Ruscica, Massimiliano
    Macchi, Chiara
    Morlotti, Beatrice
    Sirtori, Cesare R.
    Magni, Paolo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (05) : 401 - 406
  • [7] Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy?
    Eliano Pio Navarese
    Anna Szczesniak
    Michalina Kolodziejczak
    Bartosz Gorny
    Jacek Kubica
    Harry Suryapranata
    American Journal of Cardiovascular Drugs, 2014, 14 : 79 - 87
  • [8] Risk of New-Onset Diabetes Mellitus Versus Reduction in Cardiovascular Events With Statin Therapy
    Wang, Kang-Ling
    Liu, Chia-Jen
    Chao, Tze-Fan
    Chen, Su-Jung
    Wu, Cheng-Hsueh
    Huang, Chi-Ming
    Chang, Chun-Chin
    Wang, Ko-Fan
    Chen, Tzeng-Ji
    Lin, Shing-Jong
    Chiang, Chern-En
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (04): : 631 - 636
  • [9] Antihypertensive therapy and the risk of new-onset diabetes
    Sarafidis, PA
    Bakris, GL
    DIABETES CARE, 2006, 29 (05) : 1167 - 1169
  • [10] Statin Therapy and New-onset Diabetes: Molecular Mechanisms and Clinical Relevance
    Banach, Maciej
    Malodobra-Mazur, Malgorzata
    Gluba, Anna
    Katsiki, Niki
    Rysz, Jacek
    Dobrzyn, Agnieszka
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (27) : 4904 - 4912
12345